According to the new market research report "Hemostasis Analyzer Market by Product (Clinical Laboratory, consumables, reagents, PoCT, Manual, Automated), Test (PT,Fibrinogen,APTT, ACT, D Dimer), Technology (Optical, Mechanical) End User (Clinical Labs, Hospitals) - Global Forecast to 2025", published by MarketsandMarkets™, the global Coagulation Analyzer Market is projected to reach USD 5.0 billion by 2025 from USD 3.8 billion in 2020, at a CAGR of 5.7% between 2020 and 2025.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=197226392
The growth of the global Hemostasis Analyzer Market is largely driven by the increasing prevalence of cardiovascular diseases and blood disorders, technological advancements in coagulation analyzers, and the rising geriatric population. Emerging economies and growing number of reagent rental agreements are expected to offer growth opportunities to market players in the coming years.
Clinical laboratory analyzers dominated the Hemostasis Analyzer Market in 2019
Based on product, the Coagulation Analyzer Market is segmented into clinical laboratory analyzers and point-of-care testing analyzers. In 2019, the clinical laboratory analyzers segment accounted for a larger share of the market. The large share of this segment can be attributed to factors such as the growing prevalence of blood disorders and increasing development of automated coagulation systems with faster turnaround times, compact size, and expanded capabilities.
Browse in-depth TOC on "Hemostasis Analyzer Market"
105 – Tables
24 – Figures
155 – Pages
Optical technology segment accounted for the largest share of the Coagulation Analyzer Market, by technology, in 2019
The coagulation analyzers available in the market are based on three major technologies—optical technology, mechanical technology, and electrochemical technology. However, apart from these technologies, coagulation analyzers can also be based on other technologies, such as nephelometric, immunogenic, chromogenic, advanced biosensor, and thromboelastometry technologies. The most widely used technology in the Hemostasis Analyzer Market is the optical technology. This segment accounted for the largest share of the market in 2019.
Clinical laboratories dominated the Coagulation Analyzer Market in 2019
On the basis of end user, the market is segmented into clinical laboratories, hospitals, and other end users. In 2019, the clinical laboratories segment accounted for the largest share of the market.
North America is the largest regional market for coagulation analyzers
North America (comprising the US and Canada) accounted for the largest share of the global Hemostasis Analyzer Market in 2019, followed by Europe. Factors such as the increasing prevalence of lifestyle diseases and the rising incidence of blood disorders are stimulating the growth of the market in North America.
Request For Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=197226392
Siemens Healthineers (Germany), Thermo Fisher Scientific (US), Roche Diagnostics (Switzerland), Alere, Inc. (US), Sysmex Corporation (Japan), Nihon Kohden Corporation (Japan), Diagnostica Stago (France), Helena Laboratories (US), and Horiba Medical (Japan) are some of the key players operating in this Hemostasis Analyzer Market.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: [email protected]
Global On-line Total Organic Carbon (TOC) Analyzer Market by Technology (Ultraviolet Oxidation, UV Persulfate Oxidation, High-temperature Combustion), by End-User (Wastewater Treatment, and Non-Waste Water Treatment), by Application and Region – Till 2023
On-line Total Organic Carbon (TOC) analyzer measurement is primarily used to define the amount of organic contamination in water.
Canada is another major market for TOC analyzer and is expected to witness a CAGR of 4.44% during the forecast period.
With its domestic pharmaceutical industry consisting of companies such as Bayer, BASF, and Hoechst, the pharmaceutical industry has seen growth in the last few years.
Additionally, Germany is growing particularly in plant breeding and agrochemicals, making it an important destination for the TOC analyser market, in terms of growth.
Water contamination is one of the major issues in the Asia Pacific region, mainly due to increased environmental deterioration, high soil erosion, occasional floods, and increase in pollution levels in India, China, and Japan.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
Understand the various factors that will impact the market growth during the forecast period.
Also, learn about challenges faced by key players and opportunities they can leverage to grow in this market.
The Global Coagulation/Hemostasis Analyzer Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2026 gives an evaluation of the market developments based on historical studies and comprehensive research respectively.
The market segments are also provided with an in-depth outlook of the competitive landscape and a listing of the profiled key players.Coagulation/hemostasis analyzers are used to examine blood related disorders.
Hemostasis helps to stop bleeding, and coagulation are tests used to examine the hemostasis process.
Hemostasis is caused due to various deficiencies in individual platelets such as HELLP syndrome, which is due to pregnancy, or hemolytic-uremic syndrome (HUS), which is due to E. coli toxins.
Therefore these analyzers help in analyzing these disorders.
Congulometer is extensively used in medical laboratories for testing of this process.
Orbisresearch.com added latest 107 pages report “Global Online Accounting Software Market” in its store.The Global Online Accounting Software Market status, future forecast, growth opportunity, key market and key players.
The study objectives are to present the Online Accounting Software development in United States, Europe and China.The Global Online Accounting Software market size was 2914.3 million USD in 2018 and it will be 6286 million USD in 2025, with a CAGR of 11.61% from 2018 to 2025.Request a sample of this report @ http://orbisresearch.com/contacts/request-sample/3005887 .The major players in global Online Accounting Software market includeIntuitSageSAPOracle(NetSuite)MicrosoftInforEpicorWorkdayUnit4XeroYonyouKingdeeAcclivityFreshBooksZohoAssit CornerstoneMEGIReckonKashFlowGeographically, this report split global into several key Regions, with market size and growth of Online Accounting Software for these regions, from 2014 to 2025 (forecast), coveringEuropeSoutheast AsiaOther RegionsBased on product types, the Online Accounting Software market is primarily split intoSaaSASPsOn the basis on the end users/applications, this report coversManufacturingServicesRetailIf enquiry before buying this report @ http://orbisresearch.com/contacts/enquiry-before-buying/3005887 .About Us:Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements.
We have vast database of reports from the leading publishers and authors across the globe.
We specialize in delivering customized reports as per the requirements of our clients.
We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization.
This helps our clients to map their needs and we produce the perfect required market research study for our clients.Contact Us:Hector CostelloSenior Manager – Client Engagements4144N Central Expressway,Suite 600, Dallas,Texas – 75204, U.S.A.Phone No.
